Table of Contents

1 Parkinson's Disease Therapeutics Market Overview

• 1.1 Product Overview and Scope of Parkinson's Disease Therapeutics
• 1.2 Classification of Parkinson's Disease Therapeutics by Type
  • 1.2.1 Global Parkinson's Disease Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Type in 2019
  • 1.2.3 Medications Therapeutics
  • 1.2.4 Medical Devices Therapeutics
• 1.3 Global Parkinson's Disease Therapeutics Market by Application
  • 1.3.1 Overview: Global Parkinson's Disease Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Under 40 Years Old
  • 1.3.3 40-65 Years Old
  • 1.3.4 Above 65 Years Old
• 1.4 Global Parkinson's Disease Therapeutics Market by Regions
  • 1.4.1 Global Parkinson's Disease Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Parkinson's Disease Therapeutics (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 GSK
  • 2.1.1 GSK Details
  • 2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 GSK SWOT Analysis
  • 2.1.4 GSK Product and Services
  • 2.1.5 GSK Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Kyowa Hakko Kirin Pharma
  • 2.2.1 Kyowa Hakko Kirin Pharma Details
  • 2.2.2 Kyowa Hakko Kirin Pharma Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Kyowa Hakko Kirin Pharma SWOT Analysis
  • 2.2.4 Kyowa Hakko Kirin Pharma Product and Services
  • 2.2.5 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Teva Pharmaceutical
  • 2.3.1 Teva Pharmaceutical Details
  • 2.3.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Teva Pharmaceutical SWOT Analysis
  • 2.3.4 Teva Pharmaceutical Product and Services
  • 2.3.5 Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Novartis
  • 2.4.1 Novartis Details
  • 2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Novartis SWOT Analysis
  • 2.4.4 Novartis Product and Services
  • 2.4.5 Novartis Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Akorn
  • 2.5.1 Akorn Details
  • 2.5.2 Akorn Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Akorn SWOT Analysis
  • 2.5.4 Akorn Product and Services
  • 2.5.5 Akorn Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 Boehringer Ingelheim
  • 2.6.1 Boehringer Ingelheim Details
  • 2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 Boehringer Ingelheim SWOT Analysis
  • 2.6.4 Boehringer Ingelheim Product and Services
  • 2.6.5 Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 Desitin Arzneimittel
  • 2.7.1 Desitin Arzneimittel Details
  • 2.7.2 Desitin Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 Desitin Arzneimittel SWOT Analysis
  • 2.7.4 Desitin Arzneimittel Product and Services
  • 2.7.5 Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Merck
  • 2.8.1 Merck Details
  • 2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Merck SWOT Analysis
  • 2.8.4 Merck Product and Services
  • 2.8.5 Merck Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Abbvie
  • 2.9.1 Abbvie Details
  • 2.9.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Abbvie SWOT Analysis
  • 2.9.4 Abbvie Product and Services
  • 2.9.5 Abbvie Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Astellas Pharma
  • 2.10.1 Astellas Pharma Details
  • 2.10.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Astellas Pharma SWOT Analysis
  • 2.10.4 Astellas Pharma Product and Services
  • 2.10.5 Astellas Pharma Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.11 Apokyn
  • 2.11.1 Apokyn Details
  • 2.11.2 Apokyn Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.11.3 Apokyn SWOT Analysis
  • 2.11.4 Apokyn Product and Services
  • 2.11.5 Apokyn Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.12 US WorldMeds
  • 2.12.1 US WorldMeds Details
  • 2.12.2 US WorldMeds Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.12.3 US WorldMeds SWOT Analysis
  • 2.12.4 US WorldMeds Product and Services
  • 2.12.5 US WorldMeds Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.13 Endo Pharmaceuticals
  • 2.13.1 Endo Pharmaceuticals Details
  • 2.13.2 Endo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.13.3 Endo Pharmaceuticals SWOT Analysis
  • 2.13.4 Endo Pharmaceuticals Product and Services
  • 2.13.5 Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.14 Orion
  • 2.14.1 Orion Details
  • 2.14.2 Orion Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.14.3 Orion SWOT Analysis
  • 2.14.4 Orion Product and Services
  • 2.14.5 Orion Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.15 Valeant
  • 2.15.1 Valeant Details
  • 2.15.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.15.3 Valeant SWOT Analysis
  • 2.15.4 Valeant Product and Services
  • 2.15.5 Valeant Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.16 F.Hoffmann-La Roche
  • 2.16.1 F.Hoffmann-La Roche Details
  • 2.16.2 F.Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.16.3 F.Hoffmann-La Roche SWOT Analysis
  • 2.16.4 F.Hoffmann-La Roche Product and Services
  • 2.16.5 F.Hoffmann-La Roche Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.17 Bausch Health
  • 2.17.1 Bausch Health Details
  • 2.17.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.17.3 Bausch Health SWOT Analysis
  • 2.17.4 Bausch Health Product and Services
  • 2.17.5 Bausch Health Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.18 Stada Arzneimittel
  • 2.18.1 Stada Arzneimittel Details
  • 2.18.2 Stada Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.18.3 Stada Arzneimittel SWOT Analysis
  • 2.18.4 Stada Arzneimittel Product and Services
  • 2.18.3 Stada Arzneimittel Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.19 H.Lundbeck
  • 2.19.1 H.Lundbeck Details
  • 2.19.2 H.Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.19.3 H.Lundbeck SWOT Analysis
  • 2.19.4 H.Lundbeck Product and Services
  • 2.19.5 H.Lundbeck Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Parkinson's Disease Therapeutics Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Parkinson's Disease Therapeutics Players Market Share
  • 3.2.2 Top 10 Parkinson's Disease Therapeutics Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Parkinson's Disease Therapeutics Revenue and Market Share by Regions
• 4.2 North America Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 4.3 Europe Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 4.5 South America Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)

5 North America Parkinson's Disease Therapeutics Revenue by Countries

• 5.1 North America Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
• 5.2 USA Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 5.3 Canada Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)

6 Europe Parkinson's Disease Therapeutics Revenue by Countries

• 6.1 Europe Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
• 6.2 Germany Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 6.3 UK Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 6.4 France Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 6.5 Russia Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 6.6 Italy Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Parkinson's Disease Therapeutics Revenue by Countries

• 7.1 Asia-Pacific Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
• 7.2 China Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 7.3 Japan Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 7.4 Korea Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 7.5 India Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)

8 South America Parkinson's Disease Therapeutics Revenue by Countries

• 8.1 South America Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
• 8.2 Brazil Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Parkinson's Disease Therapeutics by Countries

• 9.1 Middle East & Africa Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 9.3 UAE Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Parkinson's Disease Therapeutics Revenue and Market Share by Type (2015-2020)
• 10.2 Global Parkinson's Disease Therapeutics Market Forecast by Type (2019-2024)
• 10.3 Medications Therapeutics Revenue Growth Rate (2015-2025)
• 10.4 Medical Devices Therapeutics Revenue Growth Rate (2015-2025)

11 Global Parkinson's Disease Therapeutics Market Segment by Application

• 11.1 Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2015-2020)
• 11.2 Parkinson's Disease Therapeutics Market Forecast by Application (2019-2024)
• 11.3 Under 40 Years Old Revenue Growth (2015-2020)
• 11.4 40-65 Years Old Revenue Growth (2015-2020)
• 11.5 Above 65 Years Old Revenue Growth (2015-2020)

12 Global Parkinson's Disease Therapeutics Market Size Forecast (2021-2025)

• 12.1 Global Parkinson's Disease Therapeutics Market Size Forecast (2021-2025)
• 12.2 Global Parkinson's Disease Therapeutics Market Forecast by Regions (2021-2025)
• 12.3 North America Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
• 12.4 Europe Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
• 12.6 South America Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer

Market Overview
The global Parkinson's Disease Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.8% in the forecast period of 2020 to 2025 and will expected to reach USD 3008.5 million by 2025, from USD 2405.4 million in 2019.

The Parkinson's Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Parkinson's Disease Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Parkinson's Disease Therapeutics market has been segmented into:
Medications Therapeutics
Medical Devices Therapeutics

By Application, Parkinson's Disease Therapeutics has been segmented into:
Under 40 Years Old
40-65 Years Old
Above 65 Years Old

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Parkinson's Disease Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Parkinson's Disease Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Parkinson's Disease Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Parkinson's Disease Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Parkinson's Disease Therapeutics Market Share Analysis
Parkinson's Disease Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Parkinson's Disease Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Parkinson's Disease Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Parkinson's Disease Therapeutics are:
GSK
Kyowa Hakko Kirin Pharma
Teva Pharmaceutical
Novartis
Akorn
Boehringer Ingelheim
Desitin Arzneimittel
Merck
Abbvie
Astellas Pharma
Apokyn
US WorldMeds
Endo Pharmaceuticals
Orion
Valeant
F.Hoffmann-La Roche
Bausch Health
Stada Arzneimittel
H.Lundbeck